StockNews.com Downgrades Coherus BioSciences (NASDAQ:CHRS) to Sell
StockNews.com cut shares of Coherus BioSciences (NASDAQ:CHRS – Free Report) from a hold rating to a sell rating in a research note issued to investors on Tuesday morning. Separately, HC Wainwright restated a “buy” rating and set a $7.00 price target on shares of Coherus BioSciences in a report on Tuesday, March 11th. One investment […]
StockNews.com cut shares of Coherus BioSciences (NASDAQ:CHRS – Free Report) from a hold rating to a sell rating in a research note issued to investors on Tuesday morning. Separately, HC Wainwright restated a “buy” rating and set a $7.00 price target on shares of Coherus BioSciences in a report on Tuesday, March 11th. One investment […]